DGX
Quest Diagnostics Incorporated
Diagnostics & Research · Healthcare · United States
236.04
close · 2026-08-13
value
88
cheaper than peers88
quality
52
stronger fundamentals52
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| price to sales | 2.25× | 87 |
| EV to EBITDA | 14.01× | 85 |
| forward P/E | 19.58× | 82 |
| price to book | 3.45× | 63 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 14.6% | 71 |
| operating margin | 15.2% | 65 |
| revenue growth | 10.2% | 45 |
| debt to equity | 81.1% | 29 |
4 of 4 measures available
Facts
| market cap | $26B |
| free cash flow | $909.6M |
| employees | 46,000 |
| first trade | 1996-12-17 |
| next earnings | 2026-07-23 |
| fundamentals updated | 2026-07-28 |